The combined polymorphisms of interleukin-6-174GG genotype and interleukin-10 ATA haplotype are associated with a poor quality of life in patients with chronic hepatitis C.

Publisher: Springer Netherlands Country of Publication: Netherlands NLM ID: 9210257 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2649 (Electronic) Linking ISSN: 09629343 NLM ISO Abbreviation: Qual Life Res

Publication: 2005- : Netherlands : Springer Netherlands
Original Publication: Oxford, UK : Rapid Communications of Oxford, Ltd, c1992-

Haplotypes/*genetics ; Hepatitis C, Chronic/*genetics ; Interleukin-10/*genetics ; Interleukin-6/*genetics ; Quality of Life/*psychology; Female ; Genotype ; Hepatitis C, Chronic/pathology ; Humans ; Interleukin-10/metabolism ; Interleukin-6/metabolism ; Male ; Middle Aged

Purpose: Chronic hepatitis C (CHC) is associated with a decreased health-related quality of life (HRQOL). More recent studies have pointed toward a genetic basis of patient-reported quality of life outcomes. Taking into account that the influence of single-nucleotide polymorphisms (SNPs) on the HRQOL of CHC patients has not been studied, we investigated the combined IL10-1082G/A, - 819C/T, and - 592C/A SNPs, and IL6-174G/C SNP. We also evaluated the association between demographic, clinical, psychiatric, virological, and genetic variables with domains and summaries of HRQOL in CHC patients.
Methods: 132 consecutive CHC patients and 98 controls underwent psychiatric evaluation by using the Mini International Neuropsychiatric Interview. HRQOL was assessed by a generic questionnaire, the Medical Outcomes Study 36-Item Short Form Health Survey (SF-36), and by the specific Liver Disease Quality of Life Questionnaire (LDQOL). IL6 and IL10 polymorphisms were evaluated by Taqman SNP genotyping assay. Multivariate analysis was used to evaluate the associations.
Results: Major depressive disorder was associated with lower SF-36 and LDQOL scores in seven and ten domains, respectively. Diabetes and hypertension were also associated with reduced HRQOL. CHC patients carrying the combination of IL10 ATA haplotype/IL6-GG genotype had lower scores in the SF-36-physical functioning domain, and reduced scores in the LDQOL effects of liver disease on activities of daily living, quality of social interaction, and sexual function domains than the non-carriers of the combined haplotype/genotype.
Conclusion: This is the first study to demonstrate that combined IL6 high-producer GG genotype and IL10 low-producer ATA haplotype is associated with poorer HRQOL in CHC patients.

Gut. 1999 Aug;45(2):295-300. (PMID: 10403745)
Spine (Phila Pa 1976). 2000 Dec 15;25(24):3130-9. (PMID: 11124729)
Am J Gastroenterol. 2000 Dec;95(12):3552-65. (PMID: 11151892)
Am J Gastroenterol. 2001 Jan;96(1):170-8. (PMID: 11197249)
Gastroenterology. 2001 Jan;120(1):170-8. (PMID: 11208726)
Hepatology. 2001 Mar;33(3):708-12. (PMID: 11230752)
Am J Gastroenterol. 2001 Sep;96(9):2737-44. (PMID: 11569704)
Gastroenterology. 2002 Aug;123(2):476-82. (PMID: 12145801)
JAMA. 2004 Aug 11;292(6):673-4. (PMID: 15304448)
Dig Liver Dis. 2005 Aug;37(8):593-600. (PMID: 15869912)
Med Care. 1992 Jun;30(6):473-83. (PMID: 1593914)
Health Qual Life Outcomes. 2005 Jun 16;3:39. (PMID: 15960844)
Ann Hepatol. 2005 Oct-Dec;4(4):264-71. (PMID: 16432492)
J Clin Gastroenterol. 2006 Jul;40(6):528-34. (PMID: 16825936)
J Hepatol. 2006 Dec;45(6):779-85. (PMID: 17049666)
Depress Anxiety. 2008;25(2):98-106. (PMID: 17311266)
Qual Life Res. 2008 Jun;17(5):715-24. (PMID: 18427949)
Gut. 2008 Nov;57(11):1597-603. (PMID: 18625696)
Liver Int. 2009 Mar;29(3):449-58. (PMID: 19267865)
Biol Res Nurs. 2009 Jul;11(1):27-41. (PMID: 19419979)
Clin Invest Med. 2009 Jun 01;32(3):E212-8. (PMID: 19480737)
J Viral Hepat. 2009 Sep;16(9):605-11. (PMID: 19674284)
Compr Psychiatry. 2009 Nov-Dec;50(6):549-55. (PMID: 19840593)
Biol Psychiatry. 2010 Mar 1;67(5):446-57. (PMID: 20015486)
Qual Life Res. 2010 Dec;19(10):1429-37. (PMID: 20419396)
Cancer. 2010 Sep 1;116(17):4103-13. (PMID: 20564140)
Hum Immunol. 2010 Oct;71(10):999-1004. (PMID: 20655350)
J Endocrinol Invest. 2010 Jul-Aug;33(7):501-5. (PMID: 20671409)
Qual Life Res. 2010 Dec;19(10):1395-403. (PMID: 20945161)
J Hum Hypertens. 2012 Jun;26(6):374-80. (PMID: 21593782)
Cien Saude Colet. 2011 Jul;16(7):3103-10. (PMID: 21808898)
Health Qual Life Outcomes. 2011 Aug 03;9:61. (PMID: 21812986)
Cytokine Growth Factor Rev. 2012 Feb-Apr;23(1-2):47-59. (PMID: 22390924)
Cytokine. 2012 Jun;58(3):437-47. (PMID: 22450224)
Brain Behav Immun. 2012 Aug;26(6):830-48. (PMID: 22595751)
PLoS One. 2012;7(9):e45126. (PMID: 23049769)
Health Qual Life Outcomes. 2012 Nov 16;10:134. (PMID: 23158687)
Psychosomatics. 2013 Jan-Feb;54(1):52-9. (PMID: 23295007)
J Clin Invest. 2013 Apr;123(4):1413-4. (PMID: 23543063)
World J Gastroenterol. 2013 Apr 28;19(16):2449-55. (PMID: 23674845)
Lancet. 2014 May 17;383(9930):1749-61. (PMID: 24480518)
Qual Life Res. 2014 Sep;23(7):1997-2013. (PMID: 24604075)
Aliment Pharmacol Ther. 2014 May;39(10):1180-93. (PMID: 24654740)
Rev Bras Epidemiol. 2013 Dec;16(4):889-97. (PMID: 24896594)
Oncol Nurs Forum. 2014 Sep;41(5):E267-81. (PMID: 25158664)
J Sex Marital Ther. 2015;41(6):680-90. (PMID: 25256659)
Braz J Psychiatry. 2015 Jan-Mar;37(1):21-30. (PMID: 25806552)
J Hepatol. 2015 Aug;63(2):300-2. (PMID: 25980761)
Gastroenterology. 2016 Jun;150(7):1599-1608. (PMID: 26924097)
Qual Life Res. 2016 Nov;25(11):2853-2868. (PMID: 27160108)
Curr Opin Psychiatry. 2016 Nov;29(6):331-5. (PMID: 27636599)
Liver Int. 2017 Jan;37 Suppl 1:7-12. (PMID: 28052638)
J Hepatol. 2017 Jun;66(6):1282-1299. (PMID: 28219772)
Cytokine. 2017 Jan;89:62-67. (PMID: 28340949)
Lancet Gastroenterol Hepatol. 2017 Mar;2(3):161-176. (PMID: 28404132)
Major Probl Clin Surg. 1964;1:1-85. (PMID: 4950264)
Hepatology. 1996 Aug;24(2):289-93. (PMID: 8690394)
Eur J Immunogenet. 1997 Feb;24(1):1-8. (PMID: 9043871)
Qual Life Res. 1998 Jan;7(1):39-55. (PMID: 9481150)
Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9465-70. (PMID: 9689103)
J Clin Invest. 1998 Oct 1;102(7):1369-76. (PMID: 9769329)
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57. (PMID: 9881538)

Keywords: Chronic hepatitis C; Health-related quality of life; IL10 gene polymorphism; IL6 gene polymorphism

0 (Interleukin-6)
130068-27-8 (Interleukin-10)

Date Created: 20190209 Date Completed: 20190724 Latest Revision: 20200225

20221213

10.1007/s11136-019-02129-5

30734130